Sebastian is recognised by the legal directories as a leading patent litigator and regularly acts for clients such as Roche, Gilead, Takeda, Sanofi in UK litigation, EPO oppositions and in co-ordinating actions on a pan-European basis. He has also represented clients in two important references on SPC matters to the CJEU.
Sebastian is a solicitor advocate with rights of audience in all civil proceedings in the UK. He is a member of the International Association for the Protection of Intellectual Property and an associate member of the Chartered Institute of Patent Attorneys.
Sebastian is also a guest lecturer at the University of London (on the Certificate of Intellectual Property course and the LLM course in International and Comparative Patent Law) and a tutor on the Oxford University Diploma in Intellectual Property Law and Practice.
Sebastian is recognised as Leading Individual in Pharmaceuticals and Biotechnology, and led the team which recently won Transatlantic IP Team of the Year 2017 at The American Lawyer Awards, and IP Team of The Year 2017 at The Lawyer Awards.
Winner of the Client Choice Awards (Intellectual Property: Patents) 2019
"Sebastian Moore is an SPC guru and a truly elite litigator whose pharmaceutical advocacy must be seen to be believed. Moore’s “strong sense of urgency and excellent industry understanding” make him a powerful practitioner".
IAM Patent 2019
The “brilliant” Sebastian Moore’s grasp of intricate technical details has proved invaluable to Gilead. He successfully defended the innovator giant in an infringement suit brought by Idenix relating to its blockbuster hepatitis treatment Sofosbuvir, and is coordinating continent-wide protection of its key HIV drugs.
Sebastian Moore concentrates primarily on patent litigation within the pharmaceuticals and life sciences sector. Sources say he is "an excellent litigator who is very experienced and very good with clients."
Chambers and Partners 2018
Sebastian Moore has ‘the expert touch’ in patent litigation, having acted for blue-chip multinational clients including Roche, Genentech, Biogen and Sanofi Pasteur.
Legal 500 2018
Leading Individual – Pharmaceuticals and Biotechnology,
Legal 500 2018
Winner: Transatlantic IP Team of the Year,
The American Lawyer Awards 2017
Winner: IP Team of The Year,
The Lawyer Awards 2017
"Sebastian Moore is praised by sources for his helmsmanship on complex, multi-jurisdictional pharmaceuticals patent disputes. One client says he is "one of the best lawyers I've ever worked with - the complete package.""
Chambers UK 2016
"a "leading life sciences patent litigator with encyclopaedic knowledge"
IAM 1000 2014
"Sebastian Moore is a "very thoughtful and very diligent" practitioner who "always impresses" commentators."
Chambers UK 2014
"Sebastian Moore is another of the firm's high-quality patent litigators, whom clients describe as "outstanding."
Chambers UK 2014
'Sebastian Moore has forged a formidable reputation as a patent litigator who acts for leading global names in pharmaceuticals and life sciences.'
Chambers UK 2013
'Sebastian Moore is "an excellent litigator: calm, knowledgeable and a pleasure to work with – one of the up-and-coming patent litigators"'
IAM 1000 2013
'Sebastian Moore provides "valuable advice and has an excellent understanding of the needs of the pharmaceutical industry"'
Legal 500 2012
‘… known to clients for his tactical foresight’
Chambers UK 2012
‘… a creative and smart tactician’
Chambers UK 2011
‘… excellent up-and-coming litigator ... is comfortable with a wide array of technologies’
IAM 250 – The World’s Leading Patent Litigators 2011
‘Sebastian Moore is a “fantastic solicitor”’.
Legal 500 UK 2009
‘… exceptionally competent … he is increasingly impressing clients with his “high-level approach to cases”.’
Chambers UK 2008